Pilot Award Recipient: Kellan Baker, PhD, MPH, MA
The proposed study will use quantitative data from EMR chart review and qualitative data from semistructured interviews to assess evidence for health care delivery models that leverage...
Pilot Awards Recipients
The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science.
View the archive to learn more about awards given in 2017 or earlier.
Pilot Award Recipient: Donaldson Conserve, MS, PhD
Community-based confirmatory HIV testing to support ART initiation can address the current gaps for HIVST.
Pilot Award Recipient: Lee Campbell, PhD
The current opioid epidemic has seen the rise of fentanyl among people who inject drugs (PWID) and has led to unprecedented challenges in the management and recovery of these individuals.
Pilot Award Recipient: Georges Haddad, PhD
The pandemic of the Acquired Immunodeficiency Syndrome due to the lentiviral retrovirus, Human Immunodeficiency Virus Type 1 (HIV-1) is still affecting millions of people.
Pilot Award Recipient: Yan Wang, DrPH, MD
Globally, female sex workers (FSW) are disproportionately affected by HIV compared to adult women overall.
Pilot Award Recipient: Alexander Zestos, PhD
While a number of drugs are used intravenously in people living with HIV, one group of drugs receiving increasing attention are the opiates as opiate users nearly tripled from 2009-2016.
Pilot Award Recipient: Mark Laubach, PhD
This project will investigate how toxins produced by HIV1 and antiretroviral therapies used to treat HIV impact the frontal cortex.
Pilot Award Recipient: Ruth Kanthula, MD, MPH
Antiretroviral therapy (ART) allows HIV to be managed as a chronic condition.
Pilot Award Recipient: Katherine Chiappinelli, PhD
The presence of a reservoir of latently infected cells has become the major hurdle for HIV eradication and its elimination is a scientific priority to cure HIV.
Pilot Award Recipient: Chul Kim, MD, MPH
People living with HIV (PLWH) are at risk for developing diverse malignancies.